DANA EICHER: Open Payments
NPI 1134788417 · GREENSBORO, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 10 payments from 7 companies in 2025. Trend: 2023 $303 · 2024 $567 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $236 |
| Bard Peripheral Vascular, Inc. | 1 | $146 |
| Novo Nordisk Inc | 2 | $139 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 2 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $104 |
Products named: Auvelity, Venovo, REXULTI, Wegovy, AUSTEDO XR, JARDIANCE, Ozempic.
Industry payments across AL — which companies pay providers there.
